1. Home
  2. PAHC vs EMBC Comparison

PAHC vs EMBC Comparison

Compare PAHC & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PAHC
  • EMBC
  • Stock Information
  • Founded
  • PAHC 1946
  • EMBC 1924
  • Country
  • PAHC United States
  • EMBC United States
  • Employees
  • PAHC N/A
  • EMBC N/A
  • Industry
  • PAHC Biotechnology: Pharmaceutical Preparations
  • EMBC Medical/Dental Instruments
  • Sector
  • PAHC Health Care
  • EMBC Health Care
  • Exchange
  • PAHC Nasdaq
  • EMBC Nasdaq
  • Market Cap
  • PAHC 700.3M
  • EMBC 719.1M
  • IPO Year
  • PAHC 2014
  • EMBC N/A
  • Fundamental
  • Price
  • PAHC $17.99
  • EMBC $11.82
  • Analyst Decision
  • PAHC Sell
  • EMBC Hold
  • Analyst Count
  • PAHC 4
  • EMBC 3
  • Target Price
  • PAHC $21.00
  • EMBC $17.67
  • AVG Volume (30 Days)
  • PAHC 220.8K
  • EMBC 583.1K
  • Earning Date
  • PAHC 05-07-2025
  • EMBC 05-09-2025
  • Dividend Yield
  • PAHC 2.72%
  • EMBC 5.24%
  • EPS Growth
  • PAHC 30.53
  • EMBC 2.96
  • EPS
  • PAHC 0.48
  • EMBC 0.99
  • Revenue
  • PAHC $1,106,080,000.00
  • EMBC $1,107,700,000.00
  • Revenue This Year
  • PAHC $27.84
  • EMBC N/A
  • Revenue Next Year
  • PAHC $10.22
  • EMBC $0.99
  • P/E Ratio
  • PAHC $37.78
  • EMBC $11.57
  • Revenue Growth
  • PAHC 12.63
  • EMBC N/A
  • 52 Week Low
  • PAHC $12.30
  • EMBC $10.00
  • 52 Week High
  • PAHC $26.55
  • EMBC $21.48
  • Technical
  • Relative Strength Index (RSI)
  • PAHC 42.54
  • EMBC 43.94
  • Support Level
  • PAHC $16.16
  • EMBC $10.83
  • Resistance Level
  • PAHC $18.35
  • EMBC $11.85
  • Average True Range (ATR)
  • PAHC 1.14
  • EMBC 0.67
  • MACD
  • PAHC 0.10
  • EMBC 0.06
  • Stochastic Oscillator
  • PAHC 52.97
  • EMBC 49.18

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: